BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reyentovich A, Gidea CG, Smith D, Lonze B, Kon Z, Fargnoli A, Pavone J, Rao S, Saraon T, Lewis T, Qian Y, Jacobson I, Moazami N. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors. Clin Transplant 2020;34. [DOI: 10.1111/ctr.13989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Stewart ZA, Shah SA, Rolls JA, Guarrera JV, Kandaswamy R, Axelrod DA. Best practice recommendations for the use of hepatitis C viremic donor organs for hepatitis C virus naïve recipients. Clin Transplant 2021;:e14381. [PMID: 34086371 DOI: 10.1111/ctr.14381] [Reference Citation Analysis]
2 Weinfurtner K, Reddy KR. Hepatitis C viraemic organs in solid organ transplantation. J Hepatol. 2021;74:716-733. [PMID: 33212088 DOI: 10.1016/j.jhep.2020.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kuntzen C, Bagha Z. The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients. Clinics in Liver Disease 2022. [DOI: 10.1016/j.cld.2022.01.012] [Reference Citation Analysis]
4 Villegas-galaviz J, Anderson E, Guglin M. Clinical outcomes of heart transplantation using hepatitis c-viremic donors: a systematic review with meta-analysis. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.01.010] [Reference Citation Analysis]
5 Hanif FM, Majid Z, Luck NH, Tasneem AA, Laeeq SM, Mubarak M. Revolution in the diagnosis and management of hepatitis C virus infection in current era. World J Hepatol 2022; 14(4): 647-669 [DOI: 10.4254/wjh.v14.i4.647] [Reference Citation Analysis]
6 Copeland H, Baran DA. Predicting the future: Hepatitis C donors in focus. J Heart Lung Transplant 2021:S1053-2498(21)02543-2. [PMID: 34802878 DOI: 10.1016/j.healun.2021.10.002] [Reference Citation Analysis]
7 Raasikh T, Jamali T, Flores A, Cotton RT, Ramanathan V, Tan HP, Hernaez R. Systematic review: hepatitis C viraemic allografts to hepatitis C-negative recipients in solid organ transplantation. Aliment Pharmacol Ther 2021;54:571-82. [PMID: 34265111 DOI: 10.1111/apt.16508] [Reference Citation Analysis]
8 Stewart ZA, Stern J, Ali NM, Kalia HS, Khalil K, Jonchhe S, Weldon EP, Dieter RA, Lewis TC, Funches N, Crosby S, Seow M, Berger JC, Dagher NN, Gelb BE, Watkins AC, Moazami N, Smith DE, Kon ZN, Chang SH, Reyentovich A, Angel LF, Montgomery RA, Lonze BE. Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections. Transplant Direct 2021;7:e762. [PMID: 34514117 DOI: 10.1097/TXD.0000000000001222] [Reference Citation Analysis]
9 DeFilippis EM, Khush KK, Farr MA, Fiedler A, Kilic A, Givertz MM. Evolving Characteristics of Heart Transplantation Donors and Recipients: JACC Focus Seminar. J Am Coll Cardiol 2022;79:1108-23. [PMID: 35300823 DOI: 10.1016/j.jacc.2021.11.064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Lampert BC, Kissling K. Approaches and strategies to manage the hepatitis C virus-positive heart donor. Curr Opin Organ Transplant 2022;27:229-34. [PMID: 35649114 DOI: 10.1097/MOT.0000000000000984] [Reference Citation Analysis]
11 Siddiqi HK, Schlendorf KH. Hepatitis C Positive Organ Donation in Heart Transplantation. Curr Transplant Rep 2021;:1-9. [PMID: 34786324 DOI: 10.1007/s40472-021-00350-1] [Reference Citation Analysis]
12 Baran DA, Mohammed A, Macdonald P, Copeland H. Heart Transplant Donor Selection: Recent Insights. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00355-4] [Reference Citation Analysis]